Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Should You Buy Regeneron Pharmaceuticals Stock Before Oct. 30?

Key PointsRegeneron's stock has underperformed the market this year, but it got a boost last time it reported earnings.

We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Read the original at nasdaq.com →

More in Finance & Markets

Understanding the real cost of your tax

Sean Kelly, director of Parity Wealth Managers, breaks down the compulsory taxes we pay into three buckets, how taxpayers benefit from these contributions and what households can do to combat tax…

More from Monday 28 September →